ProCE Banner Activity

CE / CME

Lysosomal Storage Disorders: Recognizing and Addressing a Group of Rare Conditions

eCourse

Lysosomal storage disorders (LSDs) are rare, inherited diseases exhibited by a broad range of symptoms and disease severity, making them difficult to diagnose. Gaucher disease is one of the most common LSDs; others include Fabry disease, Niemann-Pick disease, and Pompe disease. Patients may go years without a correct diagnosis and appropriate treatment, leading to a cycle of multiple misdirected referrals, unnecessary tests and procedures, delayed diagnosis and treatment, and disease progression. In this activity, 2 LSD experts discuss disease identification, diagnostic testing, and therapeutic strategies currently available and under investigation.

Nurse Practitioners: 1.00 Nursing contact hours, includes 1.00 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Released: December 12, 2022

Expiration: December 11, 2023

No longer available for credit.

Share

Faculty

Sarah Viall

Sarah Viall, MSN, PPCNP-BC

Assistant Professor
Department of Molecular and Medical Genetics/Department of Pediatrics
Oregon Health and Science University School of Medicine
Portland, Oregon

Neal Weinreb

Neal Weinreb, MD, FACP

Voluntary Associate Professor
Division of Human Genetics
University of Miami Miller School of Medicine
Miami, Florida

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Sanofi

Target Audience

NPs and PAs

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify signs, symptoms, and biomarkers associated with LSDs

  • Incorporate appropriate diagnostic testing and other considerations for referral in patients suspected of having an LSD

  • Describe principles of management and available treatment options as part of patient counseling

Disclosure

All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Primary Author

Sarah Viall, MSN, PPCNP-BC

Assistant Professor
Department of Molecular and Medical Genetics/Department of Pediatrics
Oregon Health and Science University School of Medicine
Portland, Oregon

Sarah Viall, MSN, PPCNP-BC, has no relevant financial relationships to disclose.

Neal Weinreb, MD, FACP

Voluntary Associate Professor
Division of Human Genetics
University of Miami Miller School of Medicine
Miami, Florida

Neal Weinreb, MD, FACP: consultant/advisor/speaker: Avrobio, Pfizer, Sanofi, Takeda.

The planners and content peer reviewers from Partners for Advancing Clinical Education and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose.

Instructions for Credit

Learners wishing to earn CE/CME credit must: 

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete evaluation form 

The estimated time to complete this activity is 1.00 hour.

Release date: December 12, 2022
Expiration date: December 11, 2022

Format

Interactive eCourse

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Partners for Advancing Clinical Education, Practicing Clinicians Exchange, or any educational supporter.

Accreditation

Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

ANCC Credit Designation

Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

 

AAPA Credit Designation

Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award 1.0 AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until December 11, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA Course Advisor: Jessica Gustafson, PA-C, Practicing Clinicians Exchange

IPCE Credit Designation
IPCE This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

This program has been made available online.